Search for: "State v. Janssen"
Results 181 - 200
of 242
Sorted by Relevance
|
Sort by Date
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
13 Aug 2008, 5:00 am
Janssen Pharmaceutica, Inc., No. 07-12259, slip op. (11th Cir. [read post]
7 May 2012, 9:12 am
This bill, which was held in committee, was introduced to overturn Brody’s decision in Bassinger v. [read post]
6 May 2016, 8:00 am
Petrillo v. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
2 Feb 2010, 7:28 am
N.J. 1981) (label change); Janssen Pharmaceutica, Inc. v. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
23 Jul 2020, 8:00 am
Janssen, 394 N.E.2d 721, 723 (Ill. [read post]
6 Jun 2017, 12:53 am
Founder v. [read post]
15 May 2022, 7:38 am
” Hebb v. [read post]
30 Aug 2021, 12:41 am
That Mellor J’s observations were not to be taken too generally was confirmed at a listing hearing in Teva v Janssen in August 2021 at which the former sought to list the trial in June 2022, 11 months after the claim form was issued. [read post]
18 Nov 2016, 12:44 am
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
2 Nov 2011, 2:00 am
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
11 Nov 2022, 9:40 am
Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
19 Dec 2006, 6:22 am
State; Kolb v. [read post]
1 May 2017, 8:00 am
Dolin, et al. v. [read post]
21 Feb 2021, 4:07 pm
On 16 February 2021 Tipples J handed down judgment in the libel and data protection case of Mueen-Uddin v Secretary of State for the Home Department [2021] EWHC 269 (QB). [read post]
